Last week we held our 7th Tele-Interviewing Seminar in Dublin, and I'm pleased to say that all of the Irish Life Assurers attended, most of which are already tele-interviewing.
In this competitive world of profit margins and cost benefits, it was great to hear of one company doing something not driven by purely economic reasons. Due to the use of Human Immunoglobulin-Anti-D in blood transfusions, about 2,000 people in Ireland are infected with Hepatitis C. The Irish government are now running a compensation scheme, part of which is to enable Hepatitis C sufferers so infected to effect life insurance cover, at standard rates, underwritten by the Irish Government. Bank of Ireland Life (BIL) is one of two life offices selling the specific life cover to these Hepat...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
